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ABSTRACT Infections with Trypanosoma cruzi are usually lifelong despite generating a
strong adaptive immune response. Identifying the sites of parasite persistence is there-
fore crucial to understanding how T. cruzi avoids immune-mediated destruction. How-
ever, this is a major technical challenge, because the parasite burden during chronic
infections is extremely low. Here, we describe an integrated approach involving
comprehensive tissue processing, ex vivo imaging, and confocal microscopy, which al-
lowed us to visualize infected host cells in murine tissue with exquisite sensitivity. Using
bioluminescence-guided tissue sampling, with a detection level of 20 parasites, we
showed that in the colon, smooth muscle myocytes in the circular muscle layer are the
most common infected host cell type. Typically, during chronic infections, the entire co-
lon of a mouse contains only a few hundred parasites, often concentrated in a small
number of cells each containing 200 parasites, which we term mega-nests. In contrast,
during the acute stage, when the total parasite burden is considerably higher and many
cells are infected, nests containing 50 parasites are rarely found. In C3H/HeN mice, but
not BALB/c mice, we identified skeletal muscle as a major site of persistence during the
chronic stage, with most parasites being found in large mega-nests within the muscle fi-
bers. Finally, we report that parasites are also frequently found in the skin during
chronic murine infections, often in multiple infection foci. In addition to being a site of
parasite persistence, this anatomical reservoir could play an important role in insect-
mediated transmission and have implications for drug development.
IMPORTANCE Trypanosoma cruzi causes Chagas disease, the most important parasitic
infection in Latin America. Major pathologies include severe damage to the heart and
digestive tract, although symptoms do not usually appear until decades after infection.
Research has been hampered by the complex nature of the disease and technical diffi-
culties in locating the extremely low number of parasites. Here, using highly sensitive
imaging technology, we reveal the sites of parasite persistence during chronic-stage in-
fections of experimental mice at single-cell resolution. We show that parasites are fre-
quently located in smooth muscle cells in the circular muscle layer of the colon and that
skeletal muscle cells and the skin can also be important reservoirs. This information pro-
vides a framework for investigating how the parasite is able to survive as a lifelong in-
fection, despite a vigorous immune response. It also informs drug development strate-
gies by identifying tissue sites that must be accessed to achieve a curative outcome.
KEYWORDS Trypanosoma cruzi, Chagas disease, chronic persistence, murine
imaging, colon, skeletal muscle, skin, chronic, persistence
The intracellular protozoan parasite Trypanosoma cruzi is the etiological agent ofChagas disease, and it can infect a wide variety of mammalian hosts. Transmission
to humans occurs mainly via the hematophagous triatomine insect vector, which
deposits infected feces on the skin after a blood meal, with the parasite then intro-
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duced through the bite wound or mucous membranes. Oral, congenital, and blood
transfusion are other important transmission routes. Six to seven million people in Latin
America are infected with T. cruzi (1), and as a result of migration, there are now
hundreds of thousands of infected individuals in regions where the disease is not
endemic, particularly the United States and Europe (2, 3).
In humans, infection normally results in mild symptoms, which can include fever and
muscle pain, although in children the outcome can be more serious. Within 6 weeks,
this acute phase is usually resolved by a vigorous CD8 T cell response (4, 5), and in
most cases, the infection progresses to a lifelong asymptomatic chronic stage, where
the parasite burden is extremely low and no apparent pathology is observed. However,
in 30% of individuals, the infection manifests as a symptomatic chronic condition,
although this can take many years to develop. The associated cardiac dysfunction,
including dilated cardiomyopathy and heart failure, is a major cause of morbidity and
mortality (6, 7). In addition, 10% of those infected display digestive pathologies, such
as megacolon and megaesophagus, which on occasions can occur in parallel with
cardiac disease. There is no vaccine against T. cruzi infection, and the current frontline
drugs, benznidazole and nifurtimox, have limited efficacy, require long treatment
regimens, and can have severe side effects (8, 9). The global effort to discover new
drugs for Chagas disease involves not-for-profit drug development consortia, as well as
the academic and commercial sectors (10, 11). Progress would benefit considerably
from a better understanding of parasite biology and pathogenesis.
One of the major challenges in Chagas disease research is to determine how T. cruzi
survives as a lifelong infection, despite eliciting a vigorous immune response which is
able to reduce the parasite burden by 99%. Exhaustion of the parasite-specific CD8
T cell response does not appear to be the reason (12). Alternative explanations include
the possibility that T. cruzi is able to persist in immune-tolerant tissue sites (13) and the
potential for the parasite to assume a nondividing dormant form that does not trigger
an overt immune response (14). Attempts to investigate these issues in humans have
been limited by the long-term and complex nature of the disease and by difficulties in
monitoring tissue infection dynamics during the chronic stage. Of necessity, most
information on the sites of parasite location in humans has come from autopsy and
transplant studies (15), and the relevance of these data to patients in the asymptomatic
chronic stage is unclear. Bioluminescence imaging of animal models has therefore been
adopted as an approach to explore aspects of host-parasite interaction, pathology, and
drug development (16–18). Our previous work and that of others exploited highly
sensitive in vivo imaging to monitor mice infected with bioluminescent T. cruzi that
expresses a red-shifted luciferase (19–21). These experiments showed that mice are
useful predictive models for human infections in terms of infection dynamics (21, 22),
drug sensitivity (23), and the spectrum of cardiac pathology (24). We have also
demonstrated that T. cruzi infection is pantropic during the acute stage and that the
adaptive immune response results in a 100- to 1,000-fold reduction in the whole-animal
parasite burden as infections transition to the chronic phase, a process initiated 2 to
3 weeks postinfection. The gastrointestinal (GI) tract, particularly the colon and/or
stomach, was found to be a major site of parasite persistence during chronic-stage
infections, but it has not so far been possible to identify the infected host cell types in
these complex tissues. The immune-mediated restriction to the GI tract was not
absolute, with both host and parasite genetics impacting the extent to which the
infection could disseminate to a range of other organs and tissues (22). The severity of
chronic cardiac pathology in different mouse strains was associated with the ability of
parasites to spread beyond the permissive niche provided by the GI tract and with the
incidence of cardiac infection. This led us to propose a model in which the develop-
ment of chagasic cardiac pathology was linked with the frequency of the localized
inflammatory immune responses stimulated by periodic trafficking of parasites into the
heart (13).
More detailed information on the precise sites of parasite survival during chronic
infections will provide new insights into pathogenesis and aid the design of both
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immunotherapeutic and chemotherapeutic strategies. The scarcity of parasites during
the chronic stage has made addressing this issue a major challenge, with PCR-based
approaches being both uninformative with respect to host cell types and unreliable
because of the highly focal and dynamic character of infections (20, 23). To resolve this,
we constructed T. cruzi reporter strains engineered to express a fusion protein that is
both bioluminescent and fluorescent (25). This allowed individual infected host cells to
be visualized routinely within chronically infected mouse tissue. The bioluminescent
component facilitates the localization of infection foci within ex vivo tissue samples, and
fluorescence then enables histological sections to be rapidly scanned to identify
infected cells (26). The utility of this approach has been further extended by using
5-ethynyl-2=-deoxyuridine (EdU) labeling and terminal deoxynucleotidyltransferase-
mediated dUTP-biotin nick end labeling (TUNEL) assays to explore the replicative status
of parasites in situ.
Here, we describe how these enhanced imaging procedures, coupled with modifi-
cations to tissue processing, have allowed us to identify the sites of parasite persistence
during chronic murine infections. We reveal that the circular muscle layer is the major
reservoir of infection in the colon, that skeletal muscle can be an important site of
persistence (although this phenomenon appears to be strain specific), and that the skin
can harbor multiple infection foci.
RESULTS
Locating the sites of T. cruzi persistence within the external wall of the colon
during chronic murine infections. In multiple murine models, with a variety of
parasite strains, bioluminescence imaging has revealed that the GI tract, particularly the
large intestine and stomach, is a major site of parasite persistence during chronic T.
cruzi infection (20, 22). However, our understanding of how this impacts pathogenesis
has been complicated by the difficulty of precisely locating, and then visualizing,
parasite-infected cells. To resolve these technical issues, we infected mice with the T.
cruzi CL-Luc::Neon line, which constitutively expresses a reporter fusion protein that is
both bioluminescent and fluorescent (25), and adapted our dissection procedures to
allow a more detailed assessment of parasite location (see Materials and Methods). At
various periods postinfection, the colon of each mouse was removed, pinned luminal
side up, and peeled into two distinct sections (Fig. 1a and b): (i) the mucosal layers,
consisting of thick mucosa, muscularis mucosa, and submucosal tissue, and (ii) the
muscular coat, including the longitudinal and circular smooth muscle layers, the enteric
neuronal network, and, at the level of the myenteric plexus, intramuscular neurons and
extrinsic nerve fibers. The resulting external gut wall mount is thin enough, and
sufficiently robust, to allow the full length of the colon to be viewed in its entirety at
a 3-dimensional level by confocal laser scanning microscopy. Using this approach, each
bioluminescent focus in peeled tissue from chronically infected mice could be corre-
lated with fluorescent parasites in individual infected host cells (Fig. 1c and d). The
resulting images revealed that the limit of detection achievable by bioluminescence
imaging is less than 20 parasites. This level of sensitivity, in an ex vivo context, confirms
the utility of this model for studies on infection dynamics (22) and drug and vaccine
efficacy (24, 27, 28). In infected host cells, the number of parasites could be determined
with precision using full-thickness serial z-stacking (Fig. 1e; Fig. S1). This allowed us to
establish that the total number of parasites persisting in the external colonic wall
(tunica muscularis) of a chronically infected mouse is typically in the range of a few
hundred (697 217; n 16), although this number can be higher if the tissue contains
one or more “mega-nests” (for an example, see Fig. 1c, highlighted in yellow).
When we compared parasite distribution in the external gut wall during acute and
chronic murine infections, the most striking difference was the presence in the chronic
stage of some host cells that were infected with 200 parasites (Fig. 2). The existence
of these mega-nests resulted in a major alteration in parasite number distribution at
the level of single infected host cells (Fig. 1; Fig. 2b to d). In acute infections, parasites
were spread among many more host cells, with the average parasite content per
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cell remaining relatively low (mouse 1 [M1], 6.5; M2, 6.7; M3, 6.5; M4, 4.6; M5, 19.7;
mean 9.4; 95% confidence interval, 1.15    16.46) (Fig. 2a, c, and d). In the
chronic stage, the situation was different. Of the total parasites in the smooth muscle,
more than half were present in mega-nests of 200 (Fig. 2c, dashed red line), although
most infected cells (90%) contained fewer than 50 parasites. Nest size could extend
to 1,000 parasites. The number per infected cell was determined by z-stacking, which
could be done with accuracy even at this level of parasite burden (for details, see Fig. S1
in the supplemental material). In the chronic stage, fully developed trypomastigotes
were not apparent in any of the infected cells examined during this study. In contrast,
fully developed flagellated trypomastigotes were routinely observed in nests during
the acute stage (for an example, see Fig. 2e). We did not find a single mega-nest in
external colonic wall tissue derived from any animal during an acute-stage infection,
with 63 parasites being the maximum. Both of these findings could indicate higher
replication and differentiation rates during the acute stage as the parasite attempts to
more rapidly disseminate at the beginning of an infection. As a corollary to this, it may
be that a lower growth rate during the chronic stage also benefits the parasite by
reducing the immunological footprint of the infection. It will be important to explore
this further.
To more accurately determine the specific location of parasites within the colon of
chronically infected mice, we made histological sections of paraffin-embedded whole
colon tissue derived from both C3H/HeN and BALB/c mice infected with the CL Brener
dual reporter strain. Using bioluminescence-guided sampling and confocal imaging, we
exhaustively searched the tissue sections for fluorescent parasites (100 sections per
mouse). Bioluminescent foci could be well correlated with individual infected host cells
FIG 1 The limit of detection by ex vivo bioluminescence imaging of the murine colon is less than 20 parasites. (a) Ex vivo bioluminescence
imaging of a section of the colon from a C3H/HeN mouse chronically infected (155 days postinfection) with T. cruzi CL-Luc::Neon (25),
pinned luminal side up. The bioluminescence signal is on a linear-scale pseudocolor heat map (same for all bioluminescence images in
this figure). (b) Schematic showing the distinct layers of the GI tract (see also Fig. 3a). The dashed red line and arrow indicate the position
above which tissue can be peeled off to leave the external colonic wall layers. (c) Bioluminescence image of a colonic wall section after
peeling. The insets show the fluorescent parasites (green) detected after exhaustive 3-dimensional imaging of the tissue section (see
Materials and Methods) and the numbers detected. Parasites corresponding to one bioluminescent focus (indicated by a question mark)
could not subsequently be found, due to technical issues. (d) (Top) External colonic wall layer from a separate mouse showing the
correlation of bioluminescence imaging and fluorescence (green), including an infection focus with 16 parasites (left) (bars, 20 m).
(Bottom) Staining with DAPI identifies the location of parasite (small) and host cell (large) DNA. (e) Determination of parasite number.
Serial z-sections of the external colonic wall tissue containing the parasite nest shown in panel d indicate how 3-dimensional imaging can
be used to calculate the number of parasites on the basis of DNA staining. See Fig. S1 for more detail.
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or small numbers of infected cells in close proximity (Fig. 3b; Fig. S2). Infected cells were
most commonly located in the circular muscle layer and only infrequently in the
longitudinal muscle, or, despite its larger size and volume, the mucosal layer (Fig. 2;
Fig. 3b and c; Fig. S2). No infections of the columnar epithelial cells in the mucosal layer
were detected in any mouse. We therefore conclude that in the colon, smooth muscle
tissue is the major, although not the exclusive, site of parasite persistence during
chronic infection. Consistent with the whole-mount imaging results (Fig. 2c), there was
high variability in the number of T. cruzi organisms per infected cell in the colonic
tissue, ranging from single parasites to nests of 200, but no obvious correlation
between the parasite burden per cell and the location of the infected cells within the
various tissue layers. In the whole-tissue mounts, based on the bioluminescence profile,
there was a tendency for the proximal region of the colon to be more highly infected
than the middle and distal regions, although this did not reach statistical significance
(Wilcoxon rank sum test) (Fig. 4a).
To identify the major cell type(s) which acts as a parasite host during chronic
infections of the GI tract, we single-stained whole mounted external colonic wall
sections with specific antibodies against SMA- (smooth muscle actin-), -tubulin-3 (a
marker for neurons), and CD45 (a broad-range marker of all nucleated hematopoietic
cells) (see Materials and Methods). These experiments showed that smooth muscle
myocytes were the predominant host cell type (Fig. 4b and c), with a minority of
infected cells stained with the neuronal or leukocyte marker. Interestingly, mega-nests,
cells infected with200 parasites, were refractive to staining (Fig. 4b). In the case of the
cytoplasmic markers SMA- and -tubulin-3, this could reflect the fact that their levels
are considerably reduced because almost all of the cytoplasm is filled with parasites.
Assessing skeletal muscle and skin as sites of parasite persistence during
chronic-stage murine infections. For this study, BALB/c and C3H/HeN mice were
chronically infected with T. cruzi CL-Luc::Neon (25), and the dissection procedures used
FIG 2 In the external colonic wall of chronic-stage mice, cells infected with more than 200 parasites contain much
of the T. cruzi population. (a) Bioluminescence imaging of peeled colon isolated from a C3H/HeN mouse 15 days
postinfection (acute stage). After mounting, the region of interest (ROI) encompassed by the red line was
exhaustively searched by confocal microscopy. Thirty-five infected cells were found within the ROI, 3 of which are
shown. Parasites are in green. (b) Using the same approach, the external colonic wall from a chronically infected
mouse (183 days postinfection) was assessed. The bioluminescent focus corresponded to a single highly infected
host cell. Bars, 20 m. (c) Pooled data from T. cruzi-infected cells in peeled colonic wall tissue muscle, isolated from
5 acutely and 16 chronically infected mice. Tissue was examined and the number of parasites per host cell
established after the use of z-stacking to provide a 3-dimensional image (Fig. S1). Each dot represents a single
infected cell (acute stage, n 1,198; chronic stage, n 140). Dots to the right of the dashed red line indicate
infected cells containing 200 parasites. (d) The same data set expressed as the percentage of the total parasites
detected in the colons of mice in the acute (n 5) and chronic (n 16) stages of infection, by nest size category.
(e) An infected cell in the peeled colon of a mouse in the acute stage (15 days postinfection) of infection in which
the parasites have differentiated to flagellated trypomastigotes.
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for ex vivo imaging (Fig. 5a) were further modified to extend the range of tissue sites
that could be assessed (see Materials and Methods). Total removal of the skin and fur
from the carcass allowed the whole of the skeletal muscle system to be exposed and
imaged (Fig. 5b and d). The skin could also be placed fur side down and imaged in its
entirety after the removal of adipose tissue. All adipose tissue harvested during the
dissection process was combined to be imaged separately.
Each C3H/HeN mouse registered a bioluminescence signal in the skeletal muscle
during chronic-stage infections (n 16) (Fig. 5c). It could be inferred from the biolu-
minescence intensity that the parasite burden in this strain was significantly higher in
skeletal muscle than in other organs or tissues, including the GI tract and lungs (P 
0.001, Wilcoxon signed-rank test) (Fig. 5b and c). As previously reported (22), parasite
burden and dissemination during chronic stage infections are more extensive in
C3H/HeN mice than in other mouse models. In line with this, we did not routinely
detect highly bioluminescent foci in the skeletal muscle of BALB/c mice (Fig. 5b and c).
In addition, levels in the adipose tissue samples of the BALB/c mice were consistently
close to background levels, whereas with the C3H/HeN mice, more than half displayed
a detectable signal (2 standard deviations [SDs] above background radiance) (Fig. 5c).
Following bioluminescence-guided excision (Fig. 5d), infected foci from C3H/HeN
skeletal muscle were subjected to histological sectioning and examined by confocal
microscopy, with parasites detected on the basis of green fluorescence. Consistent with
the external colonic wall data (Fig. 1), strong bioluminescent foci corresponded with
large mega-nests constituted by many hundreds of parasites (Fig. 5d). Costaining of
these skeletal muscle sections with anti-actin- antibodies revealed that the mega-
nests were internal to the muscle fibers. Therefore, skeletal muscle represents an
important site of parasite persistence in chronically infected C3H/HeN mice but not in
BALB/c mice.
Previous studies have shown evidence of T. cruzi infection foci localized to skin
samples (20, 22). However, the extent to which the skin could act as a potential
FIG 3 The majority of parasites in the colon of a chronically infected mouse are located in the circular muscle
section. (a) Depiction of the layers of the GI tract, correlated with the phase-contrast (left) and stained-DNA (DAPI)
(right) images of the same tissue section. (b) Examples of host cells infected with fluorescent parasites (green)
detected in different layers of the GI tract (see also Fig. S2). Infection foci were located by confocal imaging of fixed
histological sections. (c) Summary of parasite location data obtained using histological sections from chronically
infected C3H/HeN and BALB/c mice.
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reservoir site has not been evaluated systematically. To investigate this, we infected
C3H/HeN and BALB/c mice with the bioluminescent T. cruzi lines JR (DTU I) and CL
Brener (DTU VI) and employed a modified dissection protocol that allowed nearly
complete skins from infected mice to be subjected to ex vivo imaging after removal
of subcutaneous adipose tissue (see Materials and Methods) (Fig. 6a). Depending on
the infection model, between 80% and 90% of mice had at least one discernible
focus of skin infection (Fig. 6b). For all four parasite-mouse strain combinations, we
observed a wide range of skin parasitism patterns, as judged by both the number
and the intensity of the bioluminescent foci (Fig. 6a and b). There was some
evidence that C3H/HeN mice had more CL Brener skin parasites than BALB/c mice
(Fig. 6b and c). Infections with the CL Brener strain produced more discrete foci and
a higher inferred parasite load than JR infections, although some of this effect could
be attributed to lower luciferase expression levels in the JR strain (22). Skin imaging
was conducted after removal of subcutaneous adipose tissue by dissection, strongly
suggesting that the majority of parasites were resident in the dermis. To visualize
parasites at the cellular level, bioluminescence-positive biopsy specimens were
processed for thin-section fluorescence imaging from infections with parasites
expressing the bioluminescent-fluorescent fusion protein (300 sections from 5
mice). Visualization of infected cells in the skin biopsy specimens was more
challenging than for other tissues because of technical difficulties in generating
longitudinal sections. Only a single, apparently multinucleated infected cell was
identified (Fig. 6d), containing approximately 30 parasites and located within
150 m of the epidermis. Parasites in this anatomical location could have a role in
disease transmission.
FIG 4 Smooth muscle cells are the predominant infected cell type in the GI tract of chronically infected mice. (a)
Bioluminescence image of the large intestine of a chronically infected C3H/HeN mouse indicating the proximal,
middle, and distal regions, defined as the first, second, and third segments measured using image J software. Data
were analyzed as described in Materials and Methods (n 14) and are presented in the bar chart as the average
radiance (photons per second per square centimeter per steradian) minus the background. (b) Illustrative images
taken with the mounted external colonic wall section, following staining with cell type-specific antibodies (see
Materials and Methods). (Top) Infected smooth muscle cell. (Middle) Infected neuronal cell. (Bottom) A large
parasite nest, refractive to staining with any of the 3 markers. (c) Bar chart summarizing distribution of infection
by host cell type. External colonic wall sections were singly stained with cell type-specific antibodies: for smooth
muscle, SMA- (4 mice; 24 infected cells, 20 positive); for neuronal cells, -tubulin-3 (3 mice; 14 infected cells, 2
positive); for immune cells, CD45 (8 mice; 61 infected cells, 1 positive).
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DISCUSSION
Chronic Chagas disease in humans is characterized by long-term parasite persis-
tence at levels that are difficult to monitor with accuracy, even using highly sensitive
PCR-based techniques. This has been a complicating factor in diagnosis and in moni-
toring therapeutic cure during clinical trials (29, 30). Additionally, it has not been
possible to identify the main tissues and/or organs that function as sites of parasite
persistence in an immunological environment that otherwise tightly controls the
infection. Information on the systemic parasite load and location throughout the
infection would provide a better understanding of disease progression and the deter-
minants of the wide spectrum of symptoms that are characteristic of this chronic
condition. Experimental animal models have proved to be invaluable experimental
tools for providing data in these areas, particularly in combination with genetically
modified parasite reporter strains. These systems can provide real-time readouts on
infection dynamics (20, 22, 31), insights into tissue tropism (26), and information on the
influence of host and parasite genetics. The murine models used in the present study
display an infection profile similar to that in humans, have proved to be predictive of
drug efficacy, and display a spectrum of cardiac pathology that mirrors aspects of the
human disease.
Here, we exploited parasites that express fusion proteins containing bioluminescent
and fluorescent domains. Together with improved tissue preparation techniques, this
has enabled us to achieve a limit of detection by ex vivo imaging that is less than 20
FIG 5 Skeletal muscle is a major site of parasite persistence during chronic T. cruzi infections in C3H/HeN mice but not BALB/c mice. (a) Ex vivo
imaging of organs and tissues from a BALB/c mouse chronically infected with bioluminescent T. cruzi CL Brener. (b) Dorsal bioluminescence
imaging of chronically infected BALB/c and C3H/HeN mice following removal of internal organs, fur, skin, and major adipose depots (see Materials
and Methods). (c) Fold change in radiance (photons per second per square centimeter per steradian) established by ex vivo bioluminescence
imaging of internal tissues and organs and skeletal muscle as imaged in panels a and b. The dashed line indicates the detection threshold, equal
to the mean plus 2 SDs of the bioluminescence background derived from corresponding empty regions of interest in tissue from age-matched
uninfected mice. For technical reasons, on a small number of occasions, data could not be acquired for tissue samples from some mice (e.g.,
adipose tissue). (d) Bioluminescent foci from skeletal muscle were excised, and histological sections were prepared and then scanned by confocal
microscopy (see Materials and Methods). Sections were stained with specific markers for muscle (red, actin-) and DNA (blue/turquoise, DAPI).
Parasites can be identified by green fluorescence. Bars, 20 m.
Ward et al. ®
July/August 2020 Volume 11 Issue 4 e01242-20 mbio.asm.org 8
 o
n
 Septem
ber 10, 2020 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
parasites (Fig. 2d and e). By facilitating the routine detection of parasites in their tissue
context, at the level of individual host cells, these approaches have overcome a major
barrier that has restricted progress in the investigation of chronic T. cruzi infections.
Previous studies using bioluminescent parasites identified the GI tract as a major site of
parasite persistence during the chronic stage (20, 22). However, these studies, which
involved several mouse-parasite strain combinations, revealed few details on the nature
of host cells or on their precise location within tissue. We have now shown that in the
colon, the circular smooth muscle coat is the predominant site of parasite persistence
(Fig. 3) and that smooth muscle myocytes are the main infected host cell type. Enteric
neurons can also be parasitized, but such infections are much less common (Fig. 4). The
extent to which this apparent tropism is determined by a metabolic preference for the
corresponding regions or cells or by the immunological microenvironment is not
known. Interestingly, external colonic wall-resident CD45 hematopoietic cells were
rarely infected (Fig. 4a), even though myeloid cells are well-known targets during
acute-stage infection in other sites, such as the spleen and bone marrow. We also failed
to find a single instance where parasites infected epithelial cells on the mucosal surface,
suggesting that parasitized cells or trypomastigotes are unlikely to be shed into the
lumen of the large intestine.
Experiments have shown that parasite survival in the colon during chronic infections
reflects crucial differences between the immune environment of certain GI tract regions
and systemic sites (22). Immunosuppression of infected mice leads to widespread
parasite dissemination to other less permissive organs and tissues, including the heart.
FIG 6 The skin is a major site of parasite persistence during chronic T. cruzi infections in mice. (a) Ex vivo
bioluminescence imaging of skin (adipose tissue removed) from chronically infected BALB/c and C3H/HeN mice
(150 days postinfection) showing representative examples of low, medium, and high parasite loads. The biolu-
minescence signal is on a log10 scale pseudocolor heat map. (b and c) Quantification of the number of discrete
infection foci (b) and the bioluminescence intensity (c) for each skin. Data points represent individual animals, with
empty circles indicating skins having zero radiance above background. Mean values and standard errors of the
mean (SEM) are shown. Percentages in gray boxes (b) are the percentages of animals with at least one focus above
the bioluminescence threshold. Infections with both T. cruzi CL Brener and JR bioluminescent strains were assessed
(12 to 26 animals per combination, 3 to 4 independent experiments). Groups were compared by 2-way ANOVA. (d)
Confocal micrographs showing fluorescent CL Brener parasites in an infected cell within the dermis of a BALB/c
mouse 230 days postinfection (surface to the right). The asterisk indicates a gap resulting from a cutting artifact.
The bottom two images highlight the region in the white boxed area in the top image. Bars, 100 m. Magnifica-
tions, 200 (top) and 630 (middle and bottom).
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There is clearly a host genetic component to this immune restriction, since the same
parasite strains display a wider tissue distribution in C3H/HeN mice than in the BALB/c
strain (Fig. 5c), a phenomenon which is associated with increased cardiac pathology
(22). In the human population, this highlights the idea that genetic diversity affecting
the functioning of the immune system and its ability to restrict the tissue range of T.
cruzi to reservoir sites could be a major determinant of Chagas disease pathology.
Within C3H/HeN mice, skeletal muscle was also found to be an important site of
persistence during the chronic stage, whereas in the BALB/c strain, parasites were far
less evident in this location (Fig. 5c). Some T. cruzi strains have been reported to be
myotropic in mice, with pathological outcomes that include paralyzing myositis and
skeletal muscle vasculitis (32). Myocyte infections could also provide the parasite with
access to myoglobin, a source of heme or iron that may contribute to a nutritional
environment that is favorable for replication. The ability of high numbers of parasites
to survive long-term in the skeletal muscle, compared to other sites, indicates that this
tissue can function as a more immunologically permissive niche in the genetic back-
ground of the C3H/HeN mouse. Strikingly, myocytes in this tissue could contain several
hundred parasites (Fig. 5d). We have previously suggested that the existence of large
mega-nests such as these could have implications for drug efficacy (26), with parasites
in the center of the nest having reduced drug exposure compared to those on the
periphery, possibly contributing to treatment failure. This form of “herd protection”
may not be captured in the type of high-throughput in vitro screening assays that are
a common feature of the drug development process. It will also be interesting to
explore whether some parasites within these mega-nests adopt a metabolically quies-
cent state, analogous to the dormant phenotype recently reported (14).
Our study has also demonstrated that the skin is another location where T. cruzi can
frequently be detected during chronic infections. In both C3H/HeN and BALB/c mice,
infection levels of 80% were observed, although there was considerable variability in
the level of infectivity in terms of the number of bioluminescent foci and the total
parasite load. The extent of this became apparent only when the entire skin of the
mouse was examined by ex vivo imaging with the fur side down (Fig. 6), presumably
because bioluminescent signals at the levels displayed by the majority of foci are
masked by the fur when monitored by in vivo imaging. Skin-localized parasites are a
common and well-characterized feature of many Leishmania species infections. More
recently, it has also been reported that Trypanosoma brucei can also be detected in the
skin of both mice and humans and that these parasites could have important roles in
persistence and transmission (33, 34). Until now, descriptions of cutaneous T. cruzi have
been restricted to intermittent (chagoma and Romaña’s sign) or atypical manifestations
of the acute stage (35) or to reactivation of chronic infections as a result of immuno-
suppression (36, 37). Parasites in the dermal layers (Fig. 6) have the potential to play a
crucial role in transmission of Chagas disease, since they would have ready access to
the triatomine vector during a blood meal. The extent to which T. cruzi parasites are
localized to the skin during human chronic infections will also be of interest, since this
could impact transmission dynamics, as has been suggested from a detailed spatial
analysis of Leishmania donovani in the skin of infected mice (38). It will also be
important to determine whether these skin-resident parasites are persistent at this
location or whether they represent a transient population that is constantly reseeded
from other permissive niches, such as the GI tract (13). Resolution of this question will
help to inform drug design by revealing whether the ability to access parasites in the
dermal layers has to be a prerequisite property of novel therapeutics. In murine models
of T. brucei infection, adipose tissue also forms an important parasite reservoir (39). This
was not the case with chronic T. cruzi infections of BALB/c mice (Fig. 5c), where
parasites were largely absent from these tissue sites. Bioluminescent foci were detected
in the adipose tissues in approximately half of the chronically infected C3H/HeN mice.
However, rather than a specific tropism, this may simply reflect the immunological
context in C3H/HeN mice, which allows more extensive parasite distribution than in
other mouse models (22).
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In summary, we have provided new data on the sites of parasite persistence in
murine models of chronic Chagas disease. This provides a framework for identifying the
immunological parameters that determine whether a specific tissue site can act as a
permissive niche and for investigating the extent to which the parasite itself has a direct
role in the process.
MATERIALS AND METHODS
Ethics. Animal work was carried out under UK Home Office project licenses (PPL 70/8207 and
P9AEE04E4) and approved by the LSHTM Animal Welfare and Ethical Review Board. Experiments were
conducted in accordance with the UK Animals (Scientific Procedures) Act 1986.
Parasites, mice, and infections. Two parasite reporter strains were used; the bioluminescent and
fluorescent T. cruzi CL-Luc::Neon, a CL Brener clone (DTU VI) which expresses a fusion protein containing
red-shifted luciferase linked to mNeonGreen (20, 25), and a JR clone (DTU I) which expresses red-shifted
luciferase (19, 22). Epimastigotes were grown at 28°C in RPMI 1640 supplemented with 0.5% (wt/vol)
tryptone, 20 mM HEPES (pH 7.2), 30 mM hemin, 10% heatinactivated fetal bovine serum (FBS), 2 mM
sodium glutamate, 2 mM sodium pyruvate, 100 g/ml streptomycin, and 100 U/ml penicillin, with
150 g/ml hygromycin (CL Brener) or 100 g/ml G418 (JR) as selective drugs. Metacyclic trypomastigotes
(MTs) were obtained by transfer to Grace’s insect transformation medium (40). MTs were harvested after
4 to 7 days, when 70 to 90% of parasites had differentiated. Tissue culture trypomastigotes were
obtained from infected MA104 cells grown at 37°C using minimal Eagle medium supplemented with 10%
heatinactivated FBS.
BALB/c and C3H/HeN mice were purchased from Charles River (United Kingdom), and CB17 SCID
mice were bred inhouse. Animals were maintained under pathogenfree conditions in individually
ventilated cages. They experienced a 12-h light-dark cycle and had access to food and water ad libitum.
Female mice aged 8 to 12 weeks were used. SCID mice were infected with 1 104 in vitroderived tissue
culture trypomastigotes in 0.2 ml phosphate-buffered saline (PBS) via intraperitoneal (i.p.) injection.
Other mice were infected by i.p injection with 1 103 bloodstream trypomastigotes derived from blood
of parasitemic SCID mice. Infection by different routes (intravenous, subcutaneous, or oral) does not
result in different parasite distribution profiles in tissues or organs (20, 31). All SCID mice developed
fulminant infections and were euthanized at, or before, humane endpoints by lethal injection with 0.1
to 0.2 ml Dolethal.
Ex vivo bioluminescence imaging. For ex vivo imaging, mice were injected with 150 mg/kg
Dluciferin i.p. and then sacrificed by lethal i.p. injection 5 min later (20, 21). Mice were perfused with
10 ml of 0.3 mg/ml Dluciferin in PBS via the heart. Organs and tissues were imaged using the IVIS
Spectrum system (Caliper Life Science) and LivingImage 4.7.2 software. First, the heart, lungs, spleen,
liver, GI tract, GI mesenteric tissue, kidneys, and all visceral adipose tissue were transferred to a petri dish
in a standardized arrangement, soaked in 0.3 mg/ml Dluciferin in PBS, and imaged using maximum
detection settings (2-min exposure, large binning). Then, the skin was removed from the carcass, and
subcutaneous adipose tissue was recovered (41) and added to the visceral fat, creating a whole adipose
tissue sample, which was imaged in the same way. The skin was placed fur down, soaked in 0.3 mg/ml
D-luciferin, and imaged under the same conditions as the internal organs. The skeletal muscle was placed
dorsal side up, soaked in 0.3 mg/ml D-luciferin, and imaged as described above.
To assess infection intensities in ex vivo tissues, regions of interest (ROI) were drawn to quantify
bioluminescence expressed as radiance (photons per second per square centimeter per steradian).
Because different tissue types have different background radiances, we normalized data from infected
mice using matching tissues from uninfected controls (n 4) and used the fold change in radiance,
compared with the tissuespecific controls, as the final measure. Detection thresholds for ex vivo imaging
were determined using the fold change in radiance for ROI from infected mice compared with matching
empty ROI in control mice of comparable age.
In some experiments, the colon was removed after standard imaging, an incision was made down the
line of mesentery attachment, and the tissue was pinned out under a dissection microscope. Using
ultrafine tweezers, large sections of the smooth muscular coat from the other layers were peeled off,
while the tissue remained bathed in 0.3 mg/ml Dluciferin (41). After imaging, luciferin was removed by
two washes with PBS. Tissue was fixed with 4% paraformaldehyde for 45 min, followed by two washes
with PBS (41). External colonic wall tissue was then mounted whole in Vectashield antifade mounting
medium with 4=,6-diamidino-2-phenylindole (DAPI; Vector Laboratories) and imaged as described below.
Histological sections were created after bioluminescence-guided excision of infection foci from
skeletal muscle and colon tissue (25, 26, 41). Biopsy specimens were first incubated in 95% EtOH at 4°C
overnight and then washed in 100% EtOH (four times, 10 min each), followed by xylene (twice, 12 min
each). Samples were embedded by placing in melted paraffin wax (twice, 12 min each). The wax was
allowed to set, and the embedded pieces were sectioned into 5- to 20-m histological sections using a
microtome. The sections were melted, the paraffin was dissolved in xylene for 30 s, and then sections
were washed in 95% ethanol (three times, 1 min each), followed by 3 washes in PBS. Sections were
mounted in Vectashield and imaged using the Zeiss LSM880 confocal microscope. For precise counting
of intracellular parasites, samples were imaged in 3 dimensions, with the appropriate scan zoom setting,
and the files were analyzed using Image J software (Fig. S1).
Antibody staining. Deparaffinized sections were incubated at 4°C overnight in primary antibody
diluted at 1:200 in PBS–0.5% FBS. Antibodies against -tubulin-3 (catalog no. 802001; BioLegend), CD45
(catalog no. 70-0451; Tonbo Biosciences), smooth muscle actin (catalog no. A2547; Sigma), and skeletal
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muscle actin (catalog no. MA5-12542; Thermo Fisher) were used to stain for neuronal, nucleated
hematopoietic, smooth muscle, and skeletal muscle cells, respectively. Secondary antibodies (Thermo
Fisher) diluted 1:500 in PBS were incubated on sections for 3 h at room temperature before mounting.
Both primary and secondary antibodies were removed by three 2-min washes in PBS. For staining of
whole colon external wall sections, the tissue was submerged in the primary antibody dilution for 48 h
at 4°C and then submerged in the secondary dilution at room temperature for 3 h before three 2-min
washes in PBS.
Statistics. The Shapiro-Wilk test for normality and the Wilcoxon rank sum nonparametric test were
used to analyze the data presented in Fig. 4 and 5. Two-way analysis of variance (ANOVA) with Tukey’s
post hoc correction test was used for Fig. 6. All tests were performed in GraphPad Prism v.8.
SUPPLEMENTAL MATERIAL
Supplemental material is available online only.
FIG S1, TIF file, 0.3 MB.
FIG S2, TIF file, 0.7 MB.
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